<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2015-04-16 05:31:57Boehringer Ingelheim Pharmacy Respimat Dabigatran Pharmaceutical industry Tiotropium bromide Chronic Chemistry Organic chemistry Medicine |
|
| First Page | Document Content | |
|---|---|---|
Date: 2015-04-16 05:31:57Boehringer Ingelheim Pharmacy Respimat Dabigatran Pharmaceutical industry Tiotropium bromide Chronic Chemistry Organic chemistry Medicine |
|
KEY ASPECTS 2014 Andreas Barner, Wolfgang Baiker, Allan Hillgrove, Joachim Hasenmaier, Hubertus von Baumbach (from left to right), the Board of Managing Directors KEY ASPECTS 2014